Hospital
Sutter Bay Hospitals
Sutter Bay Hospitals was paid $39.50M by Medicaid between Jan 2018 and Nov 2024, across 228 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.
33Billing provider infoSUTTER BAY HOSPITALS
LAKEPORT, CA 95453
LAKEPORT, CA 95453
33aNPI1952634008assigned 09/08/2009
33bProvider typeCritical Access Hospital
28Total paid$39.50M
24GClaims457,521
24DCodes billed228
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in California
Rank by total paid#1 of 30
Median peer was paid$3.14M
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GATES, JOHN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 64,194 | $4.16M | |
| 2019 | 68,629 | $4.02M | |
| 2020 | 58,973 | $4.90M | |
| 2021 | 73,764 | $7.45M | |
| 2022 | 82,785 | $7.72M | |
| 2023 | 59,831 | $6.58M | |
| 2024incomplete | 49,345 | $4.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 32% | 51,266 | 42,669 | $12.76M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 20% | 31,084 | 27,246 | $7.85M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.1% | 2,896 | 2,842 | $2.03M |
| 70450 | Computed tomography, head or brain; without contrast material | 4.1% | 2,458 | 2,418 | $1.63M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.6% | 3,967 | 2,390 | $1.01M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.5% | 7,914 | 7,053 | $990K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.0% | 7,737 | 6,630 | $776K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 2,518 | 2,478 | $644K |
| 99201 | 1.3% | 3,016 | 1,754 | $530K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 8,571 | 1,552 | $520K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 2,919 | 2,483 | $476K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.2% | 3,230 | 3,088 | $459K |
216 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 7,415 | $453K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1.1% | 754 | $451K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 1,861 | $442K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 5,378 | $398K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 307 | $379K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,099 | $377K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 557 | $371K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,342 | $336K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,617 | $324K |
| 80053 | Comprehensive metabolic panel | <1% | 24,924 | $293K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,852 | $239K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 27,704 | $223K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,740 | $217K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,435 | $205K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,871 | $195K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,133 | $186K |
| J3490 | Unclassified drugs | <1% | 31,038 | $179K |
| 73610 | <1% | 1,656 | $168K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,076 | $156K |
| 76830 | Ultrasound, transvaginal | <1% | 1,095 | $155K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,327 | $148K |
| 73110 | <1% | 1,288 | $147K | |
| 73030 | <1% | 1,622 | $142K | |
| 73562 | <1% | 1,603 | $134K | |
| 73630 | <1% | 1,576 | $126K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 828 | $116K |
| 73130 | <1% | 1,137 | $115K | |
| 97750 | <1% | 1,081 | $114K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,601 | $96K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 161 | $91K |
| 59025 | Fetal non-stress test | <1% | 1,786 | $85K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 434 | $85K |
| 76770 | <1% | 496 | $84K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,534 | $82K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,425 | $82K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,369 | $81K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 579 | $81K |
| 97139 | <1% | 1,999 | $79K | |
| 83880 | <1% | 2,544 | $75K | |
| 82077 | <1% | 1,867 | $72K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,475 | $71K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 593 | $68K |
| 84484 | <1% | 5,717 | $65K | |
| 83690 | <1% | 8,255 | $61K | |
| 76801 | <1% | 517 | $60K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,691 | $53K |
| 90715 | <1% | 769 | $53K | |
| 80061 | Lipid panel | <1% | 4,505 | $52K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,363 | $51K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 4,660 | $50K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,684 | $49K |
| 72100 | <1% | 525 | $49K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,534 | $47K |
| 72141 | <1% | 87 | $45K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 594 | $43K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,716 | $41K |
| 87040 | <1% | 3,020 | $38K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 526 | $37K |
| 73502 | <1% | 392 | $36K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,463 | $35K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,985 | $35K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,950 | $30K |
| 81003 | <1% | 11,063 | $30K | |
| 93971 | <1% | 106 | $30K | |
| 0450 | Emergency room services | <1% | 352 | $29K |
| 85610 | <1% | 4,737 | $28K | |
| 85730 | <1% | 2,948 | $28K | |
| 73221 | <1% | 44 | $26K | |
| 83605 | <1% | 2,460 | $26K | |
| 86703 | <1% | 2,004 | $24K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,634 | $24K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 703 | $23K |
| 72110 | <1% | 213 | $22K | |
| 86803 | <1% | 1,237 | $21K | |
| 70486 | <1% | 24 | $20K | |
| 87186 | <1% | 1,837 | $18K | |
| 84439 | <1% | 2,142 | $18K | |
| 76536 | <1% | 132 | $17K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 124 | $16K |
| 87077 | <1% | 1,797 | $16K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,049 | $16K |
| 73080 | <1% | 120 | $15K | |
| 83735 | <1% | 2,395 | $15K | |
| 87081 | <1% | 2,122 | $15K | |
| 70498 | <1% | 26 | $14K | |
| 81001 | <1% | 2,994 | $14K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,369 | $14K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,124 | $13K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 303 | $12K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,449 | $12K |
| 73140 | <1% | 197 | $12K | |
| 81025 | <1% | 2,883 | $12K | |
| 86140 | <1% | 2,209 | $11K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 286 | $11K |
| 87400 | <1% | 1,358 | $11K | |
| 76642 | <1% | 90 | $10K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 268 | $10K |
| 85379 | <1% | 1,158 | $10K | |
| 10060 | <1% | 200 | $10K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $10K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,035 | $10K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 15 | $10K |
| 87430 | <1% | 895 | $10K | |
| 87899 | <1% | 1,947 | $10K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,531 | $9K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,459 | $9K |
| 80179 | <1% | 293 | $9K | |
| 87634 | <1% | 142 | $8K | |
| 86900 | <1% | 1,610 | $8K | |
| 12001 | <1% | 42 | $8K | |
| 73564 | <1% | 99 | $8K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 765 | $8K |
| 80143 | <1% | 280 | $7K | |
| 82805 | <1% | 288 | $7K | |
| 82947 | <1% | 1,126 | $7K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 639 | $7K |
| 86901 | <1% | 1,514 | $7K | |
| 86592 | <1% | 1,534 | $7K | |
| 82570 | <1% | 1,474 | $6K | |
| 72040 | <1% | 84 | $6K | |
| 71250 | <1% | 12 | $6K | |
| 86850 | <1% | 1,050 | $6K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 579 | $6K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 782 | $6K |
| 70496 | <1% | 12 | $6K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 49 | $6K |
| 85027 | <1% | 804 | $5K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 133 | $5K |
| 72050 | <1% | 51 | $5K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 26 | $5K |
| 84702 | <1% | 383 | $5K | |
| 85652 | <1% | 1,938 | $5K | |
| 87799 | <1% | 71 | $4K | |
| 87420 | <1% | 1,286 | $4K | |
| 82550 | <1% | 484 | $4K | |
| Z7502 | <1% | 91 | $3K | |
| 88142 | <1% | 588 | $3K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 444 | $3K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $3K |
| 87340 | <1% | 211 | $3K | |
| 82043 | <1% | 416 | $2K | |
| 29125 | <1% | 13 | $2K | |
| 80055 | <1% | 69 | $2K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 215 | $2K |
| 73090 | <1% | 15 | $2K | |
| 82552 | <1% | 134 | $2K | |
| 87070 | <1% | 146 | $2K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 25 | $2K |
| 86696 | <1% | 542 | $2K | |
| 86695 | <1% | 543 | $2K | |
| 80074 | <1% | 42 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 169 | $2K |
| 72070 | <1% | 12 | $1K | |
| 81002 | <1% | 385 | $1K | |
| 84481 | <1% | 66 | $1K | |
| 73590 | <1% | 14 | $1K | |
| 83540 | <1% | 228 | $1K | |
| 74018 | <1% | 27 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 127 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 47 | $1K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 29 | $1K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 112 | $1K |
| 99070 | <1% | 75 | $1K | |
| 51701 | <1% | 24 | $1K | |
| 86038 | <1% | 52 | $859.18 | |
| 84100 | <1% | 219 | $728.97 | |
| 84156 | <1% | 230 | $677.51 | |
| 83550 | <1% | 106 | $674.66 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 65 | $648.61 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 13 | $642.56 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 14 | $619.52 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 108 | $617.37 |
| 83525 | <1% | 47 | $570.98 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 35 | $549.12 |
| 85007 | <1% | 156 | $517.70 | |
| 87481 | <1% | 16 | $499.04 | |
| 82746 | <1% | 14 | $492.24 | |
| 82248 | <1% | 74 | $483.22 | |
| 87512 | <1% | 13 | $482.56 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 12 | $472.92 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 34 | $457.03 |
| 82247 | <1% | 87 | $402.51 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $397.02 |
| S0028 | Injection, famotidine, 20 mg | <1% | 77 | $392.46 |
| 84450 | <1% | 83 | $382.37 | |
| 84075 | <1% | 84 | $371.40 | |
| 82040 | <1% | 83 | $359.59 | |
| J1815 | Injection, insulin, per 5 units | <1% | 30 | $336.30 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 13 | $315.43 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 134 | $314.87 |
| 87205 | <1% | 42 | $293.12 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 66 | $262.89 |
| 84155 | <1% | 84 | $262.70 | |
| 87147 | <1% | 45 | $218.96 | |
| 82607 | <1% | 17 | $210.61 | |
| 86308 | <1% | 30 | $202.74 | |
| 83001 | <1% | 12 | $196.92 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 191 | $195.60 |
| 86762 | <1% | 15 | $193.95 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 15 | $151.04 |
| 62323 | <1% | 13 | $132.08 | |
| 82950 | <1% | 38 | $123.95 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 14 | $118.94 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 22 | $107.70 |
| 82728 | <1% | 12 | $106.26 | |
| 82553 | <1% | 12 | $100.65 | |
| 84550 | <1% | 13 | $97.52 | |
| 87088 | <1% | 16 | $97.28 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 16 | $89.04 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 289 | $82.85 |
| 87210 | <1% | 26 | $74.10 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 409 | $34.39 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 79 | $8.51 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 29 | $6.11 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 61 | $4.80 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 13 | $1.30 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGATES, JOHN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Sutter Bay Hospitals | Castro Valley, CA | $52.65M |
| Sutter Bay Hospitals | Oakland, CA | $46.80M |
| Sutter Bay Hospitals | Berkeley, CA | $43.78M |
| Sutter Bay Hospitals | Santa Rosa, CA | $35.23M |
| Sutter Bay Hospitals | Antioch, CA | $29.48M |
| Sutter Bay Hospitals | San Francisco, CA | $19.99M |
| Sutter Bay Hospitals | Burlingame, CA | $17.15M |
| Sutter Bay Hospitals | San Francisco, CA | $14.94M |
| Sutter Bay Hospitals | Novato, CA | $11.12M |
| Sutter Bay Hospitals | San Francisco, CA | $6.79M |
| Sutter Bay Hospitals | Lakeport, CA | $3.99M |
| Sutter East Bay Hospitals | Antioch, CA | $3.45M |
| Sutter Bay Hospitals | Burlingame, CA | $1.98M |
| Sutter Bay Hospitals | Lakeport, CA | $1.72M |
| Sutter East Bay Hospitals | Oakland, CA | $1.10M |
| Sutter Bay Hospitals | San Francisco, CA | $1.08M |
| Sutter East Bay Hospitals | Berkeley, CA | $946K |
| Sutter West Bay Hospitals | San Francisco, CA | $186K |
| Magnetic Imaging Affiliates, LLC | Oakland, CA | $112K |
| Sutter Bay Hospitals | Berkeley, CA | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.